share_log

CVS Health | 11-K: Annual report of employee stock purchase, savings and similar plans (and amendment thereto)

CVS Health | 11-K: Annual report of employee stock purchase, savings and similar plans (and amendment thereto)

西維斯健康 | 11-K:員工持股年度報告
美股SEC公告 ·  06/21 04:52

牛牛AI助理已提取核心訊息

CVS Health Corporation, through its CVS HEALTH FUTURE FUND 401(k) PLAN, has filed its annual report on Form 11-K for the fiscal year ended December 31, 2023, with the United States Securities and Exchange Commission. The independent audit, conducted by Ernst & Young LLP, concluded that the financial statements present fairly the net assets available for benefits and the changes in net assets available for benefits in conformity with U.S. generally accepted accounting principles. The report includes detailed financial statements, such as Statements of Net Assets Available for Benefits and Statements of Changes in Net Assets Available for Benefits, along with notes to the financial statements. The Plan's investments include mutual funds, common stock, corporate bonds, U.S. government securities, and...Show More
CVS Health Corporation, through its CVS HEALTH FUTURE FUND 401(k) PLAN, has filed its annual report on Form 11-K for the fiscal year ended December 31, 2023, with the United States Securities and Exchange Commission. The independent audit, conducted by Ernst & Young LLP, concluded that the financial statements present fairly the net assets available for benefits and the changes in net assets available for benefits in conformity with U.S. generally accepted accounting principles. The report includes detailed financial statements, such as Statements of Net Assets Available for Benefits and Statements of Changes in Net Assets Available for Benefits, along with notes to the financial statements. The Plan's investments include mutual funds, common stock, corporate bonds, U.S. government securities, and other securities, with total investments valued at $27,266,989,218. The Plan also holds synthetic guaranteed investment contracts valued at contract value. The Plan's assets and investment income have increased significantly compared to the previous year, reflecting a net increase in net assets for the year of $3,316,888,615. The Plan is subject to routine audits by taxing jurisdictions, and as of the report date, there are no audits for any tax periods in progress. The Plan's investments are managed by an independent investment consultant and approved by the Investment Subcommittee.
西維斯健康公司通過其CVS HEALTH FUTURE FUND 401(k)計劃,已向美國證券交易委員會提交了截至2023年12月31日財政年度的基本報表Form 11-K的年度報告。由安永會計事務所進行的獨立審計得出結論:財務報表遵循美國通用會計準則,公允地呈現了可獲得福利的淨資產和可獲得福利的淨資產變動。報告包括詳細的財務報表,例如可獲得福利的淨資產報表和可獲得福利的淨資產變動報表,以及財務報表附註。該計劃的投資包括股票型基金、普通股、公司債券、美國政府債券和其他證券,總投資價值爲272.66989218億美元。該計劃還持有按合同價值計價的合成保本投資合同。該計劃的資產和投資收益與前一年相比增長顯著,反映出全年淨資產增加了33.16888615億美元。該計劃受到稅務部門例行審計,截至報告日期,未進行任何任何稅期審計。該計劃的投資由獨立投資顧問管理並得到投資子委員會的批准。
西維斯健康公司通過其CVS HEALTH FUTURE FUND 401(k)計劃,已向美國證券交易委員會提交了截至2023年12月31日財政年度的基本報表Form 11-K的年度報告。由安永會計事務所進行的獨立審計得出結論:財務報表遵循美國通用會計準則,公允地呈現了可獲得福利的淨資產和可獲得福利的淨資產變動。報告包括詳細的財務報表,例如可獲得福利的淨資產報表和可獲得福利的淨資產變動報表,以及財務報表附註。該計劃的投資包括股票型基金、普通股、公司債券、美國政府債券和其他證券,總投資價值爲272.66989218億美元。該計劃還持有按合同價值計價的合成保本投資合同。該計劃的資產和投資收益與前一年相比增長顯著,反映出全年淨資產增加了33.16888615億美元。該計劃受到稅務部門例行審計,截至報告日期,未進行任何任何稅期審計。該計劃的投資由獨立投資顧問管理並得到投資子委員會的批准。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。